Tennessee Attorney General Jonathan Skrmetti recently joined 21 state attorneys general in filing an amicus brief in the Northern District of Texas in the case of Alliance for Hippocratic Medicine v. U.S. Food and Drug Administration (FDA).Read More
U.S. Representative Bob Latta (R-OH-5) is leading a charge by federal lawmakers against the Food and Drug Administration’s (FDA) relaxation of safety requirements for abortion drugs so consumers can access them by mail.
The Bowling Green-area lawmaker coauthored a letter with U.S. Senator Cindy Hyde-Smith (R-MS) and garnered signatures from 75 other members of Congress to insist that the FDA’s recent actions violate federal law. In particular, the legislators object to the agency’s approval of chemical abortion-inducing substances while no longer requiring in-person dispensing.Read More
The Food and Drug Administration (FDA) made a regulatory change that allows independent and chain drugstores, as well as mail-order companies, to offer a drug that induces abortion, making it easier for women and girls to conduct their own abortions at home or in college dorms.
The New York Times reported Tuesday evening the FDA’s regulatory change, which apparently came without an official announcement to the public, officially removes the requirement for the patient to have an in-person doctor’s visit for the prescription of mifepristone, the first drug used to induce an abortion.Read More
Worldwide religious freedom legal organization Alliance Defending Freedom (ADF) filed a federal lawsuit Friday that challenges the Food and Drug Administration’s (FDA) approval of chemical abortion drugs mifepristone and misoprostol, claiming they present significant health risks to a pregnant woman as they also starve her unborn child to death.
“[T]he FDA failed America’s women and girls when it chose politics over science and approved chemical abortion drugs for use in the United States,” the lawsuit, filed on behalf of the Alliance for Hippocratic Medicine, asserts. “And it has continued to fail them by repeatedly removing even the most basic precautionary requirements associated with their use.”Read More
The Food and Drug Administration (FDA) says abortion providers are prescribing abortion-inducing drugs to women in advance of becoming pregnant – a practice that is without authorization and potentially dangerous for women.
“The FDA is concerned about the advance prescribing of mifepristone for this use,” an anonymous FDA spokesperson reportedly told the German-owned Politico Friday. “Mifepristone is not approved for advance provision of a medical abortion.”Read More
Unregulated abortion pills are being sold over the border in Mexico and are expected to be smuggled back into the U.S. as an illegal alternative for American women looking for pregnancy termination services.
These abortion pills are readily available over the counter across the border at Mexican pharmacies, according to NPR. Nuevo Progreso is located less than half a mile from the U.S. border, making it easily accessible for Americans to buy medication in-store and for the medicine to be bought in bulk and smuggled back across the border.Read More
Planned Parenthood of Metropolitan Washington, D.C., (PPMW) is now providing telehealth abortions to people with addresses in Virginia, Maryland, and D.C., according to a September 10 press release. After a phone screening and an online consultation, PPMW mails abortion drugs to the patient. Total cost for the service is $525, including a follow-up consultation and pregnancy test.Read More